Virtus ETF Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,637
| Closed | -$347K | – | 314 |
|
|
2024
Q4 | $347K | Buy |
12,637
+1,280
| +11% | +$35.1K | 0.14% | 203 |
|
|
2024
Q3 | $289K | Hold |
11,357
| – | – | 0.14% | 231 |
|
|
2024
Q2 | $288K | Buy |
11,357
+746
| +7% | +$18.9K | 0.14% | 232 |
|
|
2024
Q1 | $328K | Buy |
10,611
+1,527
| +17% | +$47.2K | 0.17% | 221 |
|
|
2023
Q4 | $367K | Sell |
9,084
-8,934
| -50% | -$361K | 0.23% | 179 |
|
|
2023
Q3 | $475K | Sell |
18,018
-2,327
| -11% | -$61.4K | 0.29% | 174 |
|
|
2023
Q2 | $350K | Sell |
20,345
-11,903
| -37% | -$205K | 0.21% | 152 |
|
|
2023
Q1 | $535K | Buy |
32,248
+567
| +2% | +$9.4K | 0.29% | 130 |
|
|
2022
Q4 | $241K | Sell |
31,681
-4,494
| -12% | -$34.2K | 0.13% | 308 |
|
|
2022
Q3 | $360K | Buy |
36,175
+529
| +1% | +$5.26K | 0.14% | 248 |
|
|
2022
Q2 | $324K | Buy |
35,646
+31,589
| +779% | +$287K | 0.12% | 261 |
|
|
2022
Q1 | $41K | Sell |
4,057
-247
| -6% | -$2.5K | 0.02% | 366 |
|
|
2021
Q4 | $72K | Buy |
4,304
+968
| +29% | +$16.2K | 0.03% | 375 |
|
|
2021
Q3 | $156K | Sell |
3,336
-173
| -5% | -$8.09K | 0.07% | 332 |
|
|
2021
Q2 | $214K | Sell |
3,509
-1,393
| -28% | -$85K | 0.09% | 290 |
|
|
2021
Q1 | $302K | Buy |
4,902
+82
| +2% | +$5.05K | 0.13% | 240 |
|
|
2020
Q4 | $343K | Sell |
4,820
-5,933
| -55% | -$422K | 0.14% | 174 |
|
|
2020
Q3 | $403K | Sell |
10,753
-1,458
| -12% | -$54.6K | 0.21% | 167 |
|
|
2020
Q2 | $398K | Buy |
12,211
+2,351
| +24% | +$76.6K | 0.19% | 196 |
|
|
2020
Q1 | $286K | Sell |
9,860
-1,435
| -13% | -$41.6K | 0.12% | 230 |
|
|
2019
Q4 | $396K | Buy |
+11,295
| New | +$396K | 0.06% | 259 |
|